Peter Coetzee

Peter Coetzee

Auto-generated profile, based on publicly available information

Peter Coetzee

Department of Veterinary Tropical Diseases, University of Pretoria, South Africa; and, Equine Research Centre, University of Pretoria

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 September 2012 in Virology Journal
Verified
Journal Article
Open access
PDF file
PCPeter Coetzee
Peter Coetzee
MSMaria Stokstad
Maria Stokstad
Estelle VenterEstelle Venter
Estelle Venter
MMMette Myrmel
Mette Myrmel
MVMoritz Van Vuuren
Moritz Van Vuuren
Bluetongue (BT) is a non-contagious, infectious, arthropod transmitted viral disease of domestic and wild ruminants that is caused by the bluetongue virus (BTV), the prototype member of the Orbivirus genus in the family Reoviridae. Bluetongue was first described in South Africa, where it has probably been endemic in wild ruminants since antiquity. Since its discovery BT has had a major impact on sheep breeders in the country and has therefore been a key focus of research at the Onderstepoort Veterinary Research Institute in Pretoria, South Africa. Several key discoveries were made at this Institute, including the demonstration that the aetiological agent of BT was a dsRNA virus that is transmitted by Culicoides midges and that multiple BTV serotypes circulate in nature. It is currently recognized that BT is endemic throughout most of South Africa and 22 of the 26 known serotypes have been detected in the region. Multiple serotypes circulate each vector season with the occurrence of different serotypes depending largely on herd-immunity. Indigenous sheep breeds, cattle and wild ruminants are frequently infected but rarely demonstrate clinical signs, whereas improved European sheep breeds are most susceptible. The immunization of susceptible sheep remains the most effective and practical control measure against BT. In order to protect sheep against multiple circulating serotypes, three pentavalent attenuated vaccines have been developed. Despite the proven efficacy of these vaccines in protecting sheep against the disease, several disadvantages are associated with their use in the field.

1 December 2012 in Veterinary Microbiology
Verified
Journal Article
Closed access
PCPeter Coetzee
Peter Coetzee
MVMoritz Van Vuuren
Moritz Van Vuuren
MSMaria Stokstad
Maria Stokstad
MMMette Myrmel
Mette Myrmel
Estelle VenterEstelle Venter
Estelle Venter

1 March 2014 in Virus Research
Verified
Journal Article
Closed access
PCPeter Coetzee
Peter Coetzee
MVMoritz van Vuuren
Moritz van Vuuren
Estelle VenterEstelle Venter
Estelle Venter
MSMaria Stokstad
Maria Stokstad

1 August 2013 in The Veterinary Journal
Verified
Journal Article
Closed access
PCPeter Coetzee
Peter Coetzee
MSMaria Stokstad
Maria Stokstad
MMMette Myrmel
Mette Myrmel
PMPaidamwoyo Mutowembwa
Paidamwoyo Mutowembwa
TLTorleiv Loken
Torleiv Loken
MVMoritz Van Vuuren
Moritz Van Vuuren

1 December 2016 in Emerging Infectious Diseases
Verified
Journal Article
Open access
JFJosé M. Fafetine
José M. Fafetine
PCPeter Coetzee
Peter Coetzee
BMBenjamin Mubemba
Benjamin Mubemba
ONOfélia Nhambirre
Ofélia Nhambirre
LNLuis Neves
Luis Neves
Estelle VenterEstelle Venter
Estelle Venter
In early 2014, abortions and death of ruminants were reported on farms in Maputo and Gaza Provinces, Mozambique. Serologic analysis and quantitative and conventional reverse transcription PCR confirmed the presence of Rift Valley fever virus. The viruses belonged to lineage C, which is prevalent among Rift Valley fever viruses in southern Africa.

1 June 2014 in Veterinary Microbiology
Verified
Journal Article
Closed access
PCPeter Coetzee
Peter Coetzee
MVMoritz Van Vuuren
Moritz Van Vuuren
MSMaria Stokstad
Maria Stokstad
MMMette Myrmel
Mette Myrmel
RGRené G.P. van Gennip
René G.P. van Gennip
Estelle VenterEstelle Venter
Estelle Venter